RxDoctor Payments Data

Valarie Allman

Internal Medicine · Marshall, TXNPI 1689675753

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,558 and has fallen 99.0% since, to $16 in 2022.

$1,773in general payments, 2019–2025

Across 126 payments — averaging $14.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$320
  • Amgen$219
  • Novo Nordisk$178
  • Pfizer$177
  • GSK$154
  • AbbVie$124
  • plus $602 from 13 others

What the payments were for

  • Food & beverage$1,773100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,773 in reported general payments places this provider in the 75th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas →

Other internal medicine in Marshall

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →